A citation-based method for searching scientific literature

Miriam Steinschneider, Jacob Pitaro, Shlomit Koren, Yuval Mizrakli, Carlos Benbassat, Limor Muallem Kalmovich. Cancers (Basel) 2021
Times Cited: 4







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
50

Disease Progression in Papillary Thyroid Cancer with Biochemical Incomplete Response to Initial Therapy.
Nicole K Zern, Roderick Clifton-Bligh, Anthony J Gill, Ahmad Aniss, Stan Sidhu, Leigh Delbridge, Diana Learoyd, Bruce Robinson, Mark Sywak. Ann Surg Oncol 2017
8
50

Long-term clinical outcomes of papillary thyroid carcinoma patients with biochemical incomplete response.
Jonghwa Ahn, Eyun Song, Won Gu Kim, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon. Endocrine 2020
8
50

Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy.
Fernanda Vaisman, Denise Momesso, Daniel A Bulzico, Cencita H C N Pessoa, Fernando Dias, Rossana Corbo, Mário Vaisman, R Michael Tuttle. Clin Endocrinol (Oxf) 2012
156
25

Stimulated Thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid Cancers.
Bertrand Barres, Antony Kelly, Fabrice Kwiatkowski, Marie Batisse-Lignier, Geneviève Fouilhoux, Bernadette Aubert, Frédéric Dutheil, Igor Tauveron, Florent Cachin, Salwan Maqdasy. J Clin Endocrinol Metab 2019
16
25

High thyroglobulin and negative whole-body scan: no long-term benefit of empiric radioiodine therapy.
Mariana Yoshii Tramontin, Gabriela Maia Nobre, Marcia Lopes, Michel Pontes Carneiro, Paulo Alonso Garcia Alves, Fernanda Accioly de Andrade, Fernanda Vaisman, Rossana Corbo, Daniel Bulzico. Endocrine 2021
3
33

Dynamic risk stratification in the follow-up of thyroid cancer: what is still to be discovered in 2017?
Jolanta Krajewska, Ewa Chmielik, Barbara Jarząb. Endocr Relat Cancer 2017
25
25

Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients.
Livia Lamartina, Teresa Montesano, Fabiana Trulli, Marco Attard, Massimo Torlontano, Rocco Bruno, Domenico Meringolo, Fabio Monzani, Salvatore Tumino, Giuseppe Ronga,[...]. Endocrine 2016
16
25


The role of Tg kinetics in predicting 2-[18F]-FDG PET/CT results and overall survival in patients affected by differentiated thyroid carcinoma with detectable Tg and negative 131I-scan.
Domenico Albano, Mark Tulchinsky, Francesco Dondi, Angelica Mazzoletti, Francesco Bertagna, Raffaele Giubbini. Endocrine 2021
3
33





Dynamic risk assessment in patients with differentiated thyroid cancer.
Fabian Pitoia, Fernando Jerkovich. Endocr Relat Cancer 2019
17
25

Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.
Elisabetta Macerola, Barbara Loggini, Riccardo Giannini, Giulia Garavello, Mirella Giordano, Agnese Proietti, Cristina Niccoli, Fulvio Basolo, Gabriella Fontanini. Virchows Arch 2015
47
25

Special types of thyroid carcinoma.
Zubair W Baloch, Virginia A LiVolsi. Histopathology 2018
52
25

Biochemical persistence in thyroid cancer: is there anything to worry about?
Fabián Pitoia, Erika Abelleira, Hernán Tala, Fernanda Bueno, Carolina Urciuoli, Graciela Cross. Endocrine 2014
17
25


Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
Samantha Tam, Mongkol Boonsripitayanon, Moran Amit, Bryan M Fellman, Yisheng Li, Naifa L Busaidy, Maria E Cabanillas, Ramona Dadu, Steve Sherman, Steven G Waguespack,[...]. Thyroid 2018
66
25

Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile.
Carrie C Lubitz, Konstantinos P Economopoulos, Amanda C Pawlak, Kerry Lynch, Dora Dias-Santagata, William C Faquin, Peter M Sadow. Thyroid 2014
56
25

Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up.
C Giani, L Torregrossa, P Piaggi, A Matrone, D Viola, E Molinaro, L Agate, C Romei, C Ugolini, L De Napoli,[...]. Endocrine 2020
8
25

Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma.
Luca Morandi, Alberto Righi, Francesca Maletta, Paola Rucci, Fabio Pagni, Marco Gallo, Sabrina Rossi, Leonardo Caporali, Anna Sapino, Ricardo V Lloyd,[...]. Endocr Relat Cancer 2017
45
25

Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review.
Sofia Asioli, Francesca Maletta, Fabio Pagni, Donatella Pacchioni, Alice Vanzati, Sara Mariani, Nicola Palestini, Ricardo V Lloyd, Anna Sapino. Diagn Cytopathol 2014
32
25


The Hobnail Variant of Papillary Thyroid Carcinoma: Clinical/Molecular Characteristics of a Large Monocentric Series and Comparison with Conventional Histotypes.
Sara Watutantrige-Fernando, Federica Vianello, Susi Barollo, Loris Bertazza, Francesca Galuppini, Elisabetta Cavedon, Simona Censi, Clara Benna, Eric Casal Ide, Alessandro Parisi,[...]. Thyroid 2018
32
25


8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2).
Livia Lamartina, Giorgio Grani, Emanuela Arvat, Alice Nervo, Maria Chiara Zatelli, Roberta Rossi, Efisio Puxeddu, Silvia Morelli, Massimo Torlontano, Michela Massa,[...]. Endocr Relat Cancer 2018
76
25

Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.
Anne Marie Amacher, Bella Goyal, James S Lewis, Samir K El-Mofty, Rebecca D Chernock. Am J Surg Pathol 2015
38
25



Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior.
Sofia Asioli, Lori A Erickson, Alberto Righi, Ricardo V Lloyd. Hum Pathol 2013
52
25



Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis.
Lane B Donaldson, Flora Yan, Patrick F Morgan, John M Kaczmar, Jyotika K Fernandes, Shaun A Nguyen, Rachel L Jester, Terry A Day. Endocrine 2021
10
25

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.
Lianghong Teng, Wanglong Deng, Junliang Lu, Jing Zhang, Xinyu Ren, Huanli Duan, Shannon Chuai, Feidie Duan, Wei Gao, Tao Lu,[...]. Oncotarget 2017
30
25

Incidence and mortality trends of thyroid cancer from 1980 to 2016.
Simon Wirth, Maria-Eleni Syleouni, Nena Karavasiloglou, Sabina Rinaldi, Dimitri Korol, Miriam Wanner, Sabine Rohrmann. Swiss Med Wkly 2021
4
25


Exploring the Performance of Ultrasound Risk Stratification Systems in Thyroid Nodules of Pediatric Patients.
Lorenzo Scappaticcio, Maria Ida Maiorino, Sergio Iorio, Giovanni Docimo, Miriam Longo, Anna Grandone, Caterina Luongo, Immacolata Cozzolino, Arnoldo Piccardo, Pierpaolo Trimboli,[...]. Cancers (Basel) 2021
8
25


Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives.
Michele Klain, Julien Hadoux, Carmela Nappi, Monica Finessi, Raffaele Ambrosio, Martin Schlumberger, Alberto Cuocolo, Désirée Deandreis, Domenico Salvatore. Endocrine 2022
2
50



Thyroid cancer incidence disparities among ethnic Asian American populations, 1990-2014.
Alice W Lee, Roy A Mendoza, Shehla Aman, Robert Hsu, Lihua Liu. Ann Epidemiol 2022
4
25

Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.
S Mariotti, G Barbesino, P Caturegli, M Marinò, L Manetti, L Fugazzola, F Pacini, A Pinchera. J Endocrinol Invest 1994
8
25

Circulating soluble interleukin 2 receptor concentration is increased in both immunogenic and nonimmunogenic hyperthyroidism.
S Mariotti, P Caturegli, G Barbesino, G F Del Prete, L Chiovato, A Pinchera. J Endocrinol Invest 1991
21
25

Pediatric Thyroid Cancer: Genetics, Therapeutics and Outcome.
Andrew J Bauer. Endocrinol Metab Clin North Am 2020
9
25

Performance of Contrast-Enhanced Ultrasound in Thyroid Nodules: Review of Current State and Future Perspectives.
Maija Radzina, Madara Ratniece, Davis Simanis Putrins, Laura Saule, Vito Cantisani. Cancers (Basel) 2021
12
25

A long-term retrospective study of ultrasound-guided microwave ablation of thyroid benign solid nodules.
Junfeng Zhao, Linxue Qian, Yujiang Liu, Xiaoqu Tan. Int J Hyperthermia 2021
2
50

Thyroid Nodules and Thyroid Cancer in the Pregnant Woman.
Trevor E Angell, Erik K Alexander. Endocrinol Metab Clin North Am 2019
4
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.